|
End-of-day quote
Other stock markets
|
||
| - GHS | - |
|
| Market Cap | 5.2M 57.69M 4.48M 4.12M 3.88M 7.29M 490M 7.35M 48.84M 19.02M 241M 19.5M 19.09M 833M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 116M 9.01M 8.29M 7.8M 14.65M 986M 14.78M 98.19M 38.23M 484M 39.21M 38.37M 1.67B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 915K | ||
| -0.94% | -2.14% | +40.54% | +148.38% | 992B | ||
| -0.42% | -1.80% | +53.69% | +42.60% | 564B | ||
| -0.56% | -1.65% | +19.27% | +59.57% | 391B | ||
| -1.12% | +0.68% | +24.66% | +16.53% | 330B | ||
| -0.70% | -1.41% | +26.91% | +14.94% | 280B | ||
| -0.50% | -0.81% | +26.95% | +32.70% | 279B | ||
| -1.37% | +0.09% | -41.39% | -47.77% | 196B | ||
| -1.78% | +1.16% | +17.79% | +48.77% | 184B | ||
| -1.40% | +3.27% | +16.16% | +59.08% | 156B | ||
| Average | -0.71% | +0.41% | +20.51% | +41.64% | 337.12B | |
| Weighted average by Cap. | -0.40% | -0.49% | +29.33% | +65.86% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 98.73M 7.67M 7.05M 6.64M 12.47M 839M 12.58M 83.59M 32.54M 412M 33.38M 32.66M 1.42B | 9.91M 110M 8.55M 7.86M 7.4M 13.9M 935M 14.02M 93.14M 36.26M 459M 37.19M 36.4M 1.59B |
| Net income | 665K 7.38M 574K 527K 496K 933K 62.76M 941K 6.25M 2.43M 30.8M 2.5M 2.44M 107M | 762K 8.46M 657K 604K 569K 1.07M 71.87M 1.08M 7.16M 2.79M 35.27M 2.86M 2.8M 122M |
| Net Debt | 4.15M 46.04M 3.58M 3.29M 3.1M 5.82M 391M 5.87M 38.98M 15.18M 192M 15.56M 15.23M 664M | 5.25M 58.29M 4.53M 4.16M 3.92M 7.36M 495M 7.43M 49.34M 19.21M 243M 19.7M 19.28M 841M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
















